3 junio 2015
The mutation status of a gene called IDH1 might have prognostic value for anaplastic astrocytomas, and that it may be worth exploring further whether IDH1 status can predict the best chemotherapy for these patients, a new study suggests.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/TghjgoXdxkQ/150603124352.htm
